Genome-wide Association Studies-GWAS
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Statistical Significance
Controls in Experiments
Wald-Wolfowitz Runs Test II
Strategies for Assessing and Addressing Confounding
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 3, 2025

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
This study introduces an ordinal model for genome-wide association studies (GWAS), enhancing statistical power by redefining case-control outcomes. This approach boosts power, comparable to a 10% sample size increase, for genetic discovery.
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Area of Science:
Background:
Conclusions: